Skip to main content
Skip main navigationClose Drawer MenuOpen Drawer Menu

Same-Day Discharge After Elective Percutaneous Transcatheter Cardiovascular InterventionsGET ACCESS

State-of-the-Art Review

J Am Coll Cardiol Intv, 16 (13) 1561–1578
Sections

Central Illustration

Abstract

Percutaneous transcatheter interventions have evolved as standard therapies for a variety of cardiovascular diseases, from revascularization for atherosclerotic vascular lesions to the treatment of structural cardiac diseases. Concomitant technological innovations, procedural advancements, and operator experience have contributed to effective therapies with low complication rates, making early hospital discharge safe and common. Same-day discharge presents numerous potential benefits for patients, providers, and health care systems. There are several key elements that are shared across the spectrum of interventional cardiology procedures to create a successful same-day discharge pathway. These include appropriate patient and procedure selection, close postprocedural observation, predischarge assessments specific for each type of procedure, and the existence of a patient support system beyond hospital discharge. This review provides the rationale, available data, and a framework for same-day discharge across the spectrum of coronary, peripheral, and structural cardiovascular interventions.

Highlights

SDD after percutaneous transcatheter interventions is increasing.

Key elements needed for safe SDD are shared across various transcatheter procedures.

SDD candidacy requires adequate postprocedural observation and support.

SDD can benefit patient management and hospital-based resource use.

References

  • 1. Brayton K.M., Patel V.G., Stave C., de Lemos J.A., Kumbhani D.J. "Same-day discharge after percutaneous coronary intervention: a meta-analysis". J Am Coll Cardiol . 2013;62:275-285.

    View ArticleGoogle Scholar
  • 2. Ahn S.S., Tahara R.W., Jones L.E., Carr J.G., Blebea J. "Preliminary results of the Outpatient Endovascular and Interventional Society national registry". J Endovasc Ther . 2020;27:956-963.

    CrossrefMedlineGoogle Scholar
  • 3. Krishnaswamy A., Isogai T., Agrawal A., et al. "Feasibility and safety of same-day discharge following transfemoral transcatheter aortic valve replacement". J Am Coll Cardiol Intv . 2022;15:575-589.

    View ArticleGoogle Scholar
  • 4. Barker M., Sathananthan J., Perdoncin E., et al. "Same-day discharge post–transcatheter aortic valve replacement during the COVID-19 pandemic". J Am Coll Cardiol Intv . 2022;15:590-598.

    View ArticleGoogle Scholar
  • 5. Tan B.E., Boppana L.K.T., Abdullah A.S., et al. "Safety and feasibility of same-day discharge after left atrial appendage closure with the Watchman device". Circ Cardiovasc Interv . 2021;14:e009669.

    CrossrefMedlineGoogle Scholar
  • 6. Amin A.P., Pinto D., House J.A., et al. "Association of same-day discharge after elective percutaneous coronary intervention in the United States with costs and outcomes". JAMA Cardiol . 2018;3:1041-1049.

    CrossrefMedlineGoogle Scholar
  • 7. Kim M., Muntner P., Sharma S., et al. "Assessing patient-reported outcomes and preferences for same-day discharge after percutaneous coronary intervention: results from a pilot randomized, controlled trial". Circ Cardiovasc Qual Outcomes . 2013;6:186-192.

    CrossrefMedlineGoogle Scholar
  • 8. Writing Committee. Rao S.V., Vidovich M.I., et al. "2021 ACC expert consensus decision pathway on same-day discharge after percutaneous coronary intervention: a report of the American College of Cardiology Solution Set Oversight Committee". J Am Coll Cardiol . 2021;77:811-825.

    View ArticleGoogle Scholar
  • 9. Hauguel A., Maurel B., Bague N., et al. "Management of ambulatory (day case) endovascular procedures for peripheral arterial disease". J Cardiovasc Surg (Torino) . 2017;58:293-304.

    MedlineGoogle Scholar
  • 10. Perdoncin E., Greenbaum A.B., Grubb K.J., et al. "Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era". Catheter Cardiovasc Interv . 2021;97:940-947.

    CrossrefMedlineGoogle Scholar
  • 11. Gilhofer T.S., Inohara T., Parsa A., et al. "Safety and feasibility of same-day discharge after left atrial appendage closure". Can J Cardiol . 2020;36:945-947.

    CrossrefMedlineGoogle Scholar
  • 12. Centers for Medicare and Medicaid Services. "Fact sheet: two-midnight rule". https://www.cms.gov/newsroom/fact-sheets/fact-sheet-two-midnight-rule-0. Accessed February 13, 2023.

    Google Scholar
  • 13. Poon S.J., Wallis C.J.D., Lai P., Podczerwinski L., Buntin M.B. "Medicare two-midnight rule accelerated shift to observation stays". Health Aff (Millwood) . 2021;40:1688-1696.

    CrossrefMedlineGoogle Scholar
  • 14. Bradley S.M., Kaltenbach L.A., Xiang K., et al. "Trends in use and outcomes of same-day discharge following elective percutaneous coronary intervention". J Am Coll Cardiol Intv . 2021;14:1655-1666.

    View ArticleGoogle Scholar
  • 15. Heyde G.S., Koch K.T., de Winter R.J., et al. "Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS)". Circulation . 2007;115:2299-2306.

    CrossrefMedlineGoogle Scholar
  • 16. Bertrand O.F., De Larochelliere R., Rodes-Cabau J., et al. "A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation". Circulation . 2006;114:2636-2643.

    CrossrefMedlineGoogle Scholar
  • 17. Chambers C.E., Dehmer G.J., Cox D.A., et al. "Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation". Catheter Cardiovasc Interv . 2009;73:847-858.

    CrossrefMedlineGoogle Scholar
  • 18. Gilchrist I.C., Rhodes D.A., Zimmerman H.E. "A single center experience with same-day transradial-PCI patients: a contrast with published guidelines". Catheter Cardiovasc Interv . 2012;79:583-587.

    CrossrefMedlineGoogle Scholar
  • 19. Rao S.V., Kaltenbach L.A., Weintraub W.S., et al. "Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients". JAMA . 2011;306:1461-1467.

    CrossrefMedlineGoogle Scholar
  • 20. Clavijo L.C., Cortes G.A., Jolly A., et al. "Same-day discharge after coronary stenting and femoral artery device closure: a randomized study in stable and low-risk acute coronary syndrome patients". Cardiovasc Revasc Med . 2016;17:155-161.

    CrossrefMedlineGoogle Scholar
  • 21. Abdelaal E., Rao S.V., Gilchrist I.C., et al. "Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis". J Am Coll Cardiol Intv . 2013;6:99-112.

    View ArticleGoogle Scholar
  • 22. Masoudi F.A., Ponirakis A., de Lemos J.A., et al. "Trends in U.S. cardiovascular care: 2016 report from 4 ACC National Cardiovascular Data Registries". J Am Coll Cardiol . 2017;69:1427-1450.

    View ArticleGoogle Scholar
  • 23. Ferrante G., Rao S.V., Juni P., et al. "Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials". J Am Coll Cardiol Intv . 2016;9:1419-1434.

    View ArticleGoogle Scholar
  • 24. Seto A.H., Shroff A., Abu-Fadel M., et al. "Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions". Catheter Cardiovasc Interv . 2018;92:717-731.

    CrossrefMedlineGoogle Scholar
  • 25. Bundhun P.K., Soogund M.Z., Huang W.Q. "Same day discharge versus overnight stay in the hospital following percutaneous coronary intervention in patients with stable coronary artery disease: a systematic review and meta-analysis of randomized controlled trials". PLoS ONE . 2017;12:e0169807.

    CrossrefMedlineGoogle Scholar
  • 26. Taxiarchi P., Kontopantelis E., Martin G.P., et al. "Same-day discharge after elective percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society". J Am Coll Cardiol Intv . 2019;12:1479-1494.

    View ArticleGoogle Scholar
  • 27. Madan M., Bagai A., Overgaard C.B., et al. "Same-day discharge after elective percutaneous coronary interventions in Ontario, Canada". J Am Heart Assoc . 2019;8:e012131.

    CrossrefMedlineGoogle Scholar
  • 28. Koutouzis M., Liontou C., Xenogiannis I., et al. "Same day discharge after chronic total occlusion interventions: a single center experience". Catheter Cardiovasc Interv . 2021;98:1232-1239.

    CrossrefMedlineGoogle Scholar
  • 29. Taxiarchi P., Kontopantelis E., Kinnaird T., et al. "Same-day discharge after elective percutaneous coronary intervention for chronic total occlusion in the UK". J Invasive Cardiol . 2022;34:E179-E189.

    MedlineGoogle Scholar
  • 30. Glaser R., Gertz Z., Matthai W.H., et al. "Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention". J Invasive Cardiol . 2009;21:464-467.

    MedlineGoogle Scholar
  • 31. Rinfret S., Kennedy W.A., Lachaine J., et al. "Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen". J Am Coll Cardiol Intv . 2010;3:1011-1019.

    View ArticleGoogle Scholar
  • 32. Amin A.P., Patterson M., House J.A., et al. "Costs associated with access site and same-day discharge among Medicare beneficiaries undergoing percutaneous coronary intervention: an evaluation of the current percutaneous coronary intervention care pathways in the United States". J Am Coll Cardiol Intv . 2017;10:342-351.

    View ArticleGoogle Scholar
  • 33. Schulz-Schupke S., Helde S., Gewalt S., et al. "Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial". JAMA . 2014;312:1981-1987.

    CrossrefMedlineGoogle Scholar
  • 34. Wong S.C., Bachinsky W., Cambier P., et al. "A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure’s Vascular Closure Device Speeds Hemostasis Trial)". J Am Coll Cardiol Intv . 2009;2:785-793.

    View ArticleGoogle Scholar
  • 35. Slone S.E., Barringhaus K.G., Feldman B., Vismara V., Baker D. "Implementation of an accelerated discharge process following percutaneous coronary intervention for patients with non-ST elevation acute coronary syndromes". Eur J Cardiovasc Nurs . 2021;20:660-666.

    CrossrefMedlineGoogle Scholar
  • 36. Ghanbari F., Lindhardt T.B., Charlot M.G., Haahr Pedersen S., Olsen N.T. "Safety of same-day discharge after percutaneous coronary intervention in selected patients with non-ST elevation acute coronary syndrome". J Invasive Cardiol . 2021;33:E156-E163.

    MedlineGoogle Scholar
  • 37. Hariri E., Kassas I., Hammoud M.A., et al. "Same day discharge following non-elective PCI for non-ST elevation acute coronary syndromes". Am Heart J . 2022;246:125-135.

    CrossrefMedlineGoogle Scholar
  • 38. Kandan S.R., Johnson T.W. "Management of percutaneous coronary intervention complications". Heart . 2019;105:75-86.

    CrossrefMedlineGoogle Scholar
  • 39. Doll J.A., Hira R.S., Kearney K.E., et al. "Management of percutaneous coronary intervention complications: algorithms from the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference". Circ Cardiovasc Interv . 2020;13:e008962.

    CrossrefGoogle Scholar
  • 40. Jabara R., Gadesam R., Pendyala L., et al. "Ambulatory discharge after transradial coronary intervention: preliminary US single-center experience (Same-Day Transradial Intervention and Discharge Evaluation, the STRIDE study)". Am Heart J . 2008;156:1141-1146.

    CrossrefMedlineGoogle Scholar
  • 41. Small A., Klinke P., Della Siega A., et al. "Day procedure intervention is safe and complication free in higher risk patients undergoing transradial angioplasty and stenting. The DISCHARGE study". Catheter Cardiovasc Interv . 2007;70:907-912.

    CrossrefMedlineGoogle Scholar
  • 42. Writing Committee M., Lawton J.S., Tamis-Holland J.E., et al. "2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol . 2022;79:e21-e129.

    View ArticleGoogle Scholar
  • 43. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al. "2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol . 2017;69:e71-e126.

    View ArticleGoogle Scholar
  • 44. Mohapatra A., Saadeddin Z., Bertges D.J., et al. "Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries". J Vasc Surg . 2020;71:560-566.

    CrossrefMedlineGoogle Scholar
  • 45. Rowe V.L., Lee W., Weaver F.A., Etzioni D. "Patterns of treatment for peripheral arterial disease in the United States: 1996-2005". J Vasc Surg . 2009;49:910-917.

    CrossrefMedlineGoogle Scholar
  • 46. "Medicare program; prospective payment system for long-term care hospitals RY 2008: annual payment rate updates, and policy changes; and hospital direct and indirect graduate medical education policy changes. Final rule". Fed Regist . 2007;72:26869-27029.

    MedlineGoogle Scholar
  • 47. Jones W.S., Mi X., Qualls L.G., et al. "Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system". J Am Coll Cardiol . 2015;65:920-927.

    View ArticleGoogle Scholar
  • 48. Gouicem D., Palcau L., Le Hello C., et al. "Feasibility of ambulatory percutaneous femoral access without the use of arterial closure systems". Ann Vasc Surg . 2014;28:132-136.

    CrossrefMedlineGoogle Scholar
  • 49. Spiliopoulos S., Karnabatidis D., Katsanos K., et al. "Day-case treatment of peripheral arterial disease: results from a multi-center European study". Cardiovasc Intervent Radiol . 2016;39:1684-1691.

    CrossrefMedlineGoogle Scholar
  • 50. Ansari A., Shah M.A., Shah M.A., Ansari Z. "Safety of day-case endovascular interventions for peripheral arterial disease in a rural, underserved area". Ther Adv Cardiovasc Dis . 2020;14:1753944720948651.

    CrossrefMedlineGoogle Scholar
  • 51. Kwan T.W., Shah S., Amoroso N., et al. "Feasibility and safety of routine transpedal arterial access for treatment of peripheral artery disease". J Invasive Cardiol . 2015;27:327-330.

    MedlineGoogle Scholar
  • 52. Jain K., Munn J., Rummel M.C., Johnston D., Longton C. "Office-based endovascular suite is safe for most procedures". J Vasc Surg . 2014;59:186-191.

    CrossrefMedlineGoogle Scholar
  • 53. Huang D.Y., Ong C.M., Walters H.L., et al. "Day-case diagnostic and interventional peripheral angiography: 10-year experience in a radiology specialist nurse-led unit". Br J Radiol . 2008;81:537-544.

    CrossrefMedlineGoogle Scholar
  • 54. Islam A.M., Alreja G., Mallidi J., Ziaul Hoque M., Friderici J. "Feasibility, safety, and patient satisfaction of same-day discharge following peripheral arterial interventions: a randomized controlled study". Catheter Cardiovasc Interv . 2018;92:358-363.

    CrossrefMedlineGoogle Scholar
  • 55. Kruse J.R., Cragg A.H. "Safety of short stay observation after peripheral vascular intervention". J Vasc Interv Radiol . 2000;11:45-49.

    CrossrefMedlineGoogle Scholar
  • 56. Burns B.J., Phillips A.J., Fox A., Boardman P., Phillips-Hughes J. "The timing and frequency of complications after peripheral percutaneous transluminal angioplasty and iliac stenting: is a change from inpatient to outpatient therapy feasible?"Cardiovasc Intervent Radiol . 2000;23:452-456.

    CrossrefMedlineGoogle Scholar
  • 57. Levin S.R., Carlson S.J., Farber A., et al. "Percutaneous radial artery access for peripheral vascular interventions is a safe alternative for upper extremity access". J Vasc Surg . 2022;76:1: 174-179.e2.

    CrossrefMedlineGoogle Scholar
  • 58. Ortiz D., Jahangir A., Singh M., Allaqaband S., Bajwa T.K., Mewissen M.W. "Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes". Circ Cardiovasc Interv . 2014;7:821-828.

    CrossrefMedlineGoogle Scholar
  • 59. Bhardwaj B., Spertus J.A., Kennedy K.F., et al. "Bleeding complications in lower-extremity peripheral vascular interventions: insights from the NCDR PVI Registry". J Am Coll Cardiol Intv . 2019;12:1140-1149.

    View ArticleGoogle Scholar
  • 60. Safley D.M., Salisbury A.C., Tsai T.T., et al. "Acute kidney injury following in-patient lower extremity vascular intervention: from the National Cardiovascular Data Registry". J Am Coll Cardiol Intv . 2021;14:333-341.

    View ArticleGoogle Scholar
  • 61. Carroll J.D., Mack M.J., Vemulapalli S., et al. "STS-ACC TVT Registry of transcatheter aortic valve replacement". J Am Coll Cardiol . 2020;76:2492-2516.

    View ArticleGoogle Scholar
  • 62. Wood D.A., Lauck S.B., Cairns J.A., et al. "The Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study". J Am Coll Cardiol Intv . 2019;12:459-469.

    View ArticleGoogle Scholar
  • 63. Pop A.M., Barker M., Hickman L., et al. "Same day discharge during the COVID-19 pandemic in highly selected transcatheter aortic valve replacement patients". Structural Heart . 2021;5:596-604.

    CrossrefMedlineGoogle Scholar
  • 64. Giri J., Fiorilli P.N. "Did the COVID-19 pandemic just turn TAVR into an outpatient procedure?"J Am Coll Cardiol Intv . 2022;15:599-602.

    View ArticleGoogle Scholar
  • 65. Vemulapalli S., Carroll J.D., Mack M.J., et al. "Procedural volume and outcomes for transcatheter aortic-valve replacement". N Engl J Med . 2019;380:2541-2550.

    CrossrefMedlineGoogle Scholar
  • 66. Sanchez C.E., Hermiller J.B., Pinto D.S., et al. "Predictors and risk calculator of early unplanned hospital readmission following contemporary self-expanding transcatheter aortic valve replacement from the STS/ACC TVT Registry". Cardiovasc Revasc Med . 2020;21:263-270.

    CrossrefMedlineGoogle Scholar
  • 67. Kolte D., Khera S., Sardar M.R., et al. "Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the Nationwide Readmissions Database". Circ Cardiovasc Interv . 2017;10:e004472.

    CrossrefGoogle Scholar
  • 68. Abawi M., Nijhoff F., Agostoni P., et al. "Incidence, predictive factors, and effect of delirium after transcatheter aortic valve replacement". J Am Coll Cardiol Intv . 2016;9:160-168.

    View ArticleGoogle Scholar
  • 69. Mangieri A., Lanzillo G., Bertoldi L., et al. "Predictors of advanced conduction disturbances requiring a late (>/=48 h) permanent pacemaker following transcatheter aortic valve replacement". J Am Coll Cardiol Intv . 2018;11:1519-1526.

    View ArticleGoogle Scholar
  • 70. Ream K., Sandhu A., Valle J., et al. "Ambulatory rhythm monitoring to detect late high-grade atrioventricular block following transcatheter aortic valve replacement". J Am Coll Cardiol . 2019;73:2538-2547.

    View ArticleGoogle Scholar
  • 71. Rodes-Cabau J., Urena M., Nombela-Franco L., et al. "Arrhythmic burden as determined by ambulatory continuous cardiac monitoring in patients with new-onset persistent left bundle branch block following transcatheter aortic valve replacement: the MARE study". J Am Coll Cardiol Intv . 2018;11:1495-1505.

    View ArticleGoogle Scholar
  • 72. Isogai T., Dykun I., Agrawal A., et al. "Early resolution of new-onset left bundle branch block after transcatheter aortic valve implantation with the SAPIEN 3 valve". Am J Cardiol . 2022;168:117-127.

    CrossrefMedlineGoogle Scholar
  • 73. Rodés-Cabau J., Ellenbogen K.A., Krahn A.D., et al. "Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific expert panel". J Am Coll Cardiol . 2019;74:1086-1106.

    View ArticleGoogle Scholar
  • 74. Reiter C., Lambert T., Kellermair J., et al. "Delayed total atrioventricular block after transcatheter aortic valve replacement assessed by implantable loop recorders". J Am Coll Cardiol Intv . 2021;14:2723-2732.

    View ArticleGoogle Scholar
  • 75. Muntane-Carol G., Okoh A.K., Chen C., et al. "Ambulatory electrocardiographic monitoring following minimalist transcatheter aortic valve replacement". J Am Coll Cardiol Intv . 2021;14:2711-2722.

    View ArticleGoogle Scholar
  • 76. Muntane-Carol G., Philippon F., Nault I., et al. "Ambulatory electrocardiogram monitoring in patients undergoing transcatheter aortic valve replacement: JACC state-of-the-art review". J Am Coll Cardiol . 2021;77:1344-1356.

    View ArticleGoogle Scholar
  • 77. Krishnaswamy A., Sammour Y., Mangieri A., et al. "The utility of rapid atrial pacing immediately post-TAVR to predict the need for pacemaker implantation". J Am Coll Cardiol Intv . 2020;13:1046-1054.

    View ArticleGoogle Scholar
  • 78. Writing Committee M., Otto C.M., Nishimura R.A., et al. "2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol . 2021;77:e25-e197.

    View ArticleGoogle Scholar
  • 79. Mack M., Carroll J.D., Thourani V., et al. "Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT Registry". J Am Coll Cardiol . 2021;78:2326-2353.

    View ArticleGoogle Scholar
  • 80. Chowdhury M., Buttar R., Rai D., et al. "Same-day discharge after transcatheter mitral valve repair using MitraClip in a tertiary community hospital: a case series". Eur Heart J Case Rep . 2021;5:ytab397.

    CrossrefMedlineGoogle Scholar
  • 81. Marmagkiolis K., Kilic I.D., Ates I., Kose G., Iliescu C., Cilingiroglu M. "Feasibility of same-day discharge approach after transcatheter mitral valve repair procedures". J Invasive Cardiol . 2021;33:E123-E126.

    MedlineGoogle Scholar
  • 82. Jobs A., Grund S., de Waha-Thiele S., et al. "Deep sedation versus general anaesthesia for transcatheter mitral valve repair: an individual patient data meta-analysis of observational studies". EuroIntervention . 2021;16:1359-1365.

    CrossrefMedlineGoogle Scholar
  • 83. Steppich B., Stegmuller F., Rumpf P.M., et al. "Vascular complications after percutaneous mitral valve repair and venous access closure using suture or closure device". J Interv Cardiol . 2018;31:223-229.

    CrossrefMedlineGoogle Scholar
  • 84. Geis N.A., Pleger S.T., Chorianopoulos E., Muller O.J., Katus H.A., Bekeredjian R. "Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair". EuroIntervention . 2015;10:1346-1353.

    CrossrefMedlineGoogle Scholar
  • 85. January C.T., Wann L.S., Calkins H., et al. "2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". J Am Coll Cardiol . 2019;74:104-132.

    View ArticleGoogle Scholar
  • 86. Reddy V.Y., Doshi S.K., Sievert H., et al. "Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial". Circulation . 2013;127:720-729.

    CrossrefMedlineGoogle Scholar
  • 87. Holmes D.R., Kar S., Price M.J., et al. "Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial". J Am Coll Cardiol . 2014;64:1-12.

    View ArticleGoogle Scholar
  • 88. Vuddanda V.L.K., Turagam M.K., Umale N.A., et al. "Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: a US nationwide retrospective cohort study using claims data". Heart Rhythm . 2020;17:374-382.

    CrossrefMedlineGoogle Scholar
  • 89. Osmancik P., Herman D., Neuzil P., et al. "Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation". J Am Coll Cardiol . 2020;75:3122-3135.

    View ArticleGoogle Scholar
  • 90. Boersma L.V., Ince H., Kische S., et al. "Efficacy and safety of left atrial appendage closure with Watchman in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial". Heart Rhythm . 2017;14:1302-1308.

    CrossrefMedlineGoogle Scholar
  • 91. Freeman J.V., Varosy P., Price M.J., et al. "The NCDR Left Atrial Appendage Occlusion Registry". J Am Coll Cardiol . 2020;75:1503-1518.

    View ArticleGoogle Scholar
  • 92. Lakkireddy D., Thaler D., Ellis C.R., et al. "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): a randomized, controlled trial". Circulation . 2021;144:1543-1552.

    CrossrefMedlineGoogle Scholar
  • 93. Marmagkiolis K., Ates I., Kose G., Iliescu C., Cilingiroglu M. "Effectiveness and safety of same day discharge after left atrial appendage closure under moderate conscious sedation". Catheter Cardiovasc Interv . 2021;97:912-916.

    CrossrefMedlineGoogle Scholar
  • 94. Dallan L.A.P., Bezerra H.G., Cochet A., et al. "Safety, efficacy, and cost-effectiveness of same-day discharge for left atrial appendage occlusion". J Invasive Cardiol . 2022;34:E124-E131.

    MedlineGoogle Scholar
  • 95. Piayda K., Afzal S., Nielsen-Kudsk J.E., et al. "Length of stay following percutaneous left atrial appendage occlusion: data from the prospective, multicenter Amplatzer Amulet occluder observational study". PLoS ONE . 2021;16:e0255721.

    CrossrefMedlineGoogle Scholar
  • 96. Kar S., Doshi S.K., Sadhu A., et al. "Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial". Circulation . 2021;143:1754-1762.

    CrossrefMedlineGoogle Scholar
  • 97. Kapadia S. "Real-world outcomes with Watchman FLX: early results from SURPASS". Presented at: CRT22; February 28, 2022.

    Google Scholar
  • 98. Gibson D., Price M., Piccini J., et al. "Safety and effectiveness of same day discharge after left atrial appendage occlusion with Watchman FLX". Presented at: Heart Rhythm . 2022. April 30, 2022.

    CrossrefGoogle Scholar
  • 99. Nielsen-Kudsk J.E., Berti S., De Backer O., et al. "Use of intracardiac compared with transesophageal echocardiography for left atrial appendage occlusion in the Amulet observational study". J Am Coll Cardiol Intv . 2019;12:1030-1039.

    View ArticleGoogle Scholar
  • 100. Alkhouli M., Chaker Z., Alqahtani F., Raslan S., Raybuck B. "Outcomes of routine intracardiac echocardiography to guide left atrial appendage occlusion". J Am Coll Cardiol EP . 2020;6:393-400.

    Google Scholar
  • 101. Isogai T., Saad A.M., Shekhar S., et al. "Incidence and outcomes of pericardial effusion/tamponade following percutaneous left atrial appendage closure". Am J Cardiol . 2021;160:126-129.

    CrossrefMedlineGoogle Scholar
  • 102. Stout K.K., Daniels C.J., Aboulhosn J.A., et al. "2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol . 2019;73:e81-e192.

    View ArticleGoogle Scholar
  • 103. Mas J.L., Derumeaux G., Guillon B., et al. "Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke". N Engl J Med . 2017;377:1011-1021.

    CrossrefMedlineGoogle Scholar
  • 104. Saver J.L., Carroll J.D., Thaler D.E., et al. "Long-term outcomes of patent foramen ovale closure or medical therapy after stroke". N Engl J Med . 2017;377:1022-1032.

    CrossrefMedlineGoogle Scholar
  • 105. Bijl J.M., Ruygrok P.N., Hornung T.S., Wilson N.J., West T. "Percutaneous closure of patent foramen ovale". Intern Med J . 2005;35:706-710.

    CrossrefMedlineGoogle Scholar
  • 106. Ponnuthurai F.A., van Gaal W.J., Burchell A., Mitchell A.R., Wilson N., Ormerod O.J. "Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography". Int J Cardiol . 2009;131:438-440.

    CrossrefMedlineGoogle Scholar
  • 107. Barker M., Muthuppalaniappan A.M., Abrahamyan L., et al. "Periprocedural outcomes of fluoroscopy-guided patent foramen ovale closure with selective use of intracardiac echocardiography". Can J Cardiol . 2020;36:1608-1615.

    CrossrefMedlineGoogle Scholar
  • 108. Prashar A., Shah S., Zhang R., Mitchell K., Sader M. "Safety and cost implications of same-day discharge following elective percutaneous closure of patent foramen ovale and atrial septal defects in Australia". Hearts . 2021;2:543-550.

    CrossrefGoogle Scholar
  • 109. Turner D.R., Owada C.Y., Sang C.J., Khan M., Lim D.S. "Closure of secundum atrial septal defects with the Amplatzer Septal Occluder: a prospective, multicenter, post-approval study". Circ Cardiovasc Interv . 2017;10:e004212.

    CrossrefGoogle Scholar
  • 110. Abaci A., Unlu S., Alsancak Y., Kaya U., Sezenoz B. "Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies". Catheter Cardiovasc Interv . 2013;82:1123-1138.

    CrossrefMedlineGoogle Scholar